• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients

    2022-10-24 09:11:30YueXuChiXieYanFangYanYuCuiQiu
    International Journal of Ophthalmology 2022年10期

    Yue Xu, Chi Xie, Yan Fang, Yan Yu, Cui Qiu

    1Department of Ophthalmology, the First Affiliated Hospital of Anhui University of Science & Technology, Huainan 232001,Anhui Province, China

    2Institute of Ophthalmology, Anhui University of Science &Technology, Huainan 232001, Anhui Province, China

    Abstract

    ● KEYWORDS: preoperative timing; intravitreal anti-VEGF injection; angio-fibrosis switch; proliferative diabetic retinopathy

    INTRODUCTION

    Proliferative diabetic retinopathy (PDR) is a serious ocular microvascular complication of diabetes characterized by pathological neovascularization with or without fibrovascular proliferation[1-3]. Disease progression leads to contraction of proliferative fibrovascular membranes (FVMs) that can cause vitreous hemorrhage (VH) and tractional retinal detachment(TRD) eventually leading to blindness. Many studies have confirmed that vascular endothelial growth factor (VEGF)is an important inducing factor involved in this pathological process, and its levels are closely related to the severity of PDR[4-7]. Therefore, in the past 10y, VEGF inhibitors (anti-VEGFs) have been widely used as adjunct treatment for PDR patients. At present, intravitreal anti-VEGF injections (IVI) are performed as an important ancillary treatment in combination with pars plana vitrectomy (PPV) in PDR patients[8-9].

    It is undeniable that the clinical results of PDR patients treated with preoperative IVI combined with PPV are significantly better than those of patients treated with PPV alone. Numerous retrospective studies have confirmed that preoperative IVI can promote regression of neovascularization, minimize intraoperative bleeding during segmentation of FVMs, shorten operation time, and reduce the occurrence of postoperative VH, as well as decrease the likelihood of other intraoperative and postoperative-associated complications[10-13]. Moreover,the visual prognosis of patients treated with preoperative IVI combined with PPV was better than that of patients treated with PPV alone.

    Although the emergence of anti-VEGF drugs marks a great progress in the treatment of PDR, an increasing number of studies have provided evidence that IVI is effective in some PDR patients, while others develop progressive severity of fibrosis, especially when the interval between IVI and PPV is long[14-17].Liet al[18]showed that the timing of anti-VEGF therapy played an important role in the development of fibrosis, supporting the idea that the timing of preoperative IVI can be an important factor in determining whether anti-VEGF treatment will be a beneficial or detrimental adjunct to PPV.

    At present, the mechanism of fibrosis aggravation after IVI remains unclear. Klaassenet al[19]proposed that this phenomenon was related to the angio-fibrotic switch. In other words, at some point there was a transition from angiogenesis inhibition to fibrosis promotion. Therefore, we theorize that IVI not only blocks VEGF but also causes changes in the concentrations of other cytokines in PDR patients.

    The aim of the present study was to analyze the concentrations of various cytokines in the vitreous fluid and to correlate this with the severity of fibrosis in PDR patients based on different lengths of time between IVI and PPV, and to elucidate the specific molecular mechanism of the angio-fibrosis switch, so as to provide a reference for retinal surgeons to the optimal timing for anti-VEGF treatment.

    SUBJECTS AND METHODS

    Ethical ApprovalThe study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the institutional review board and Ethical Committee of the First Affiliated Hospital of Anhui University of Science & Technology. All patients voluntarily signed informed consent after having been provided with a detailed description of the treatment.

    PatientsWe conducted a prospective case-control study of 31 eyes of 31 PDR patients (PDR group) and 21 eyes of 21 non-diabetic controls including patients with macular hole or rhegmatogenous retinal detachment (control group) who underwent 23-G PPV at the Ophthalmology Department of the First Affiliated Hospital of Anhui University of Science &Technology in Huainan, China, between January 2019 and July 2020.

    The surgical indications of the PDR group included persistent VH and TRD with proliferative FVMs. The exclusion criteria included the following: 1) a history of previous ocular surgery (e.g., phacoemulsification, trabeculectomy),2) previous treatment with anti-VEGF therapy or pan-retinal photocoagulation within 6mo, 3) a history of topical antiinflammatory drops like as nepafenac, 4) presence of other retinal neovascular diseases (e.g., retinal vein occlusion), 5)presence of other ocular diseases that seriously affect visual function (e.g., keratitis, optic neuritis, uveitis, high myopia,and amblyopia).

    Eligible PDR patients were divided into two groups, one group was pre-treated with IVI prior to PPV (n=26; IVI PDR group)and the other group was not pretreated with IVI (n=5; no IVI group). The IVI PDR group was further subdivided into three groups based on the timing of pretreatment: 1) PDR patients who underwent PPV 3d after IVI (n=9; 3-day group); 2)PDR patients who underwent PPV 5d after IVI (n=10; 5-day group); 3) PDR patients who underwent PPV ≥7d after IVI(n=7; ≥7-day group). Two kinds of anti-VEGF drugs were used in IVI PDR group, of which 3, 6, and 3 eyes were pretreated with intravitreal conbercept injections respectively in 3-day group, 5-day group and ≥7-day group and 6, 4, 4 eyes were pre-treated with ranibizumab respectively. There was no statistical difference in the types of anti-VEGF drugs among subgroups (χ2=1.397,P=0.497).

    ExaminationsAll patients underwent comprehensive preoperative ophthalmic and medical examinations. Eye examinations included slit-lamp biomicroscopy, intraocular pressure (IOP) measurement, ocular B-scan ultrasonography,ultra-wide-angle fundus photography, and spectral domain optical coherence tomography (SD-OCT). Fundus fluorescein angiography (FFA) was used to assess macular perfusion status if necessary.

    The degree of vitreoretinal fibrosis in PDR patients was graded according to the classification reported byKuiperet al[20]as follows:grade 0, no fibrosis; grade 1, few pre-retinal membranes; grade 2, white preretinal fibrotic membranes with limited extension into the vitreous; grade 3, abundant white membranes reaching into the vitreous body.

    Sample CollectionUndiluted vitreous fluid samples (0.5-1 mL) were obtained before PPV without switching on the infusion fluid. The samples were centrifuged at 3000 g for 10min at 4℃ and the supernatant was immediately transferred to a different sterile Eppendorf?tube. All preliminary centrifuged samples were stored in the refrigerator at -80℃ until further analysis.

    Measurement of CytokinesviaLuminex TechnologyA human premixed multi-analyte kit (R&D Systems, Austin, TX,USA) was used to measure the concentrations of cytokines in vitreous fluid samples. The cytokines measured included VEGF, basic fibroblast growth factor (bFGF), periostin (PN),interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α.The preliminary centrifuged samples were diluted 2-fold with calibrator diluent RD6-52. First, 50 μL of the diluted sample and microparticle cocktail were added to each well of the microplate and incubated for 2h at room temperature on a horizontal orbital microplate shaker (0.12s orbit) set at 800±50 rpm. Afterwards, the microplate was washed by removing the liquid from each well, filling the wells with 100 μL wash buffer, and removing the liquid again; this procedure was performed three times. Next, 50 μL of diluted biotin-antibody cocktail were added to each well and incubated for 1h at room temperature on the shaker set at 800 rpm.Subsequently, the wash was repeated as described above,followed by the addition of 50 μL of diluted Streptavidin-PE to each well and incubation for 30min at room temperature on the shaker set at 800 rpm. Following this, the wash was repeated for the third time and 100 μL of wash buffer were added to each well and incubated for 2min at room temperature on the shaker set at 800 rpm. Finally, the concentration values were obtained from the mean fluorescent intensity (MFI) by using Luminex 200? System (xPONENT Software). Standard curves were generated from the reference cytokine gradient concentrations. The concentrations of cytokines in vitreous fluid samples were calculated from the standard curves.

    Statistical AnalysisSPSS 22.0 software (SPSS, Inc., Chicago,IL, USA) was used for statistical analysis. The Shapiro-Wilk test was performed to examine whether the data were distributed normally. Data are presented as the mean±standard deviation (SD) or as median and range. Statistical significances of cytokine concentration among the groups were determined using the Kruskal-WallisHtest with Bonferroni post hoc test,while differences between two groups were estimated using a non-parametric Mann-WhitneyUtest. Aχ2or Fisher exact test was conducted to compare noncontinuous variables.The spearman rank correlation test was used to analyze the correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines. Based on the results of univariate analysis, the degree of vitreoretinal fibrosis was taken as the dependent variable, and the factors ofP<0.05 were included in the multivariate regression model for multivariate ordered logistic regression analysis. AP-value <0.05 was considered statistically significant.

    RESULTS

    Patient CharacteristicsCharacteristics of the 52 patients studied are shown in Table 1. Statistical analysis demonstrated that there was no significant difference in sex (P=1.000) and age (P=0.178) among the IVI PDR group, no IVI PDR group,and the control group. There was also no significant difference in hemoglobin A1c (HbA1c) and indication for PPV between the pretreated and non-pretreated PDR groups (P=0.755, 0.525,1.000, and 1.000, respectively; allP>0.05; Table 1).

    Vitreous Fluid Cytokine ConcentrationsThe cytokine concentration values for the IVI PDR group, no IVI PDR group, and the control group are shown in Table 2. The concentrations of VEGF, bFGF, PN, and IL-6 were all significantly higher in the no IVI group than in the control group (Z=-3.420, -2.279, -2.950, and -3.027, respectively; allP<0.05), while no significant differences were observed in IL-8 and TNF-α between the two groups (bothP>0.05). In addition,the IVI group had a significantly lower concentration of VEGF(Z=-3.491,P<0.05) and a significantly higher concentration of IL-8 (Z=-2.363,P<0.05) than the no IVI group. While there were no significant differences in bFGF, PN, IL-6, and TNF- α concentrations between the two groups (allP>0.05).

    There were significant differences in VEGF, bFGF, PN, IL-6,IL-8, and TNF-α concentrations in the vitreous fluid among the five groups (F=42.105, 36.653, 33.396, 28.517, 26.554, and 18.326, respectively; allP<0.01; Figure 1).

    We further compared the concentrations of cytokines among the 3-day group, 5-day group, and ≥7-day group and discovered that the differences in VEGF, bFGF, PN, IL-6, and IL-8 concentrations were statistically significant (F=13.077,16.524, 10.440, 7.748, and 8.960, respectively; allP<0.05).There was no significant difference among the 3 subgroups in TNF-α concentration (F=2.978,P=0.226).

    Vitreous fluid samples in the 5-day group had the lowest concentration of VEGF, and this was statistically significant compared with the 3-day group (P=0.002) and the ≥7-day group (P=0.024). However, there was no significant difference in the concentrations of vitreous VEGF between the 3-day group and ≥7-day group (P>0.05).

    In addition, vitreous fluid samples in the ≥7-day group had the highest concentrations of bFGF and PN, and this was statistically significant compared with the 3-day group(P=0.000,P=0.008, respectively) and the 5-day group(P=0.012,P=0.020, respectively). No significant differences were found in the concentrations of vitreous bFGF and PN between the 3-day group and 5-day group (bothP>0.05).The concentrations of IL-6 and IL-8 in the ≥7-day group were both significantly higher than in the 3-day group (P=0.019,P=0.014, respectively), whereas no significant differences in IL-6 and IL-8 concentrations were observed between the 5-day group and ≥7-day group (bothP>0.05), as well as between the 3-day group and 5-day group (bothP>0.05; Figure 2).

    Figure 1 Concentrations of cytokines in vitreous fluid of patients in each group VEGF: Vascular endothelial growth factor; IVI: Intravitreal anti-VEGF injections; bFGF: Basic fibroblast growth factor; IL: Interleukin; TNF: Tumor necrosis factor.

    Table 1 Patient characteristics

    Table 2 Concentrations of cytokines in vitreous fluid of patients in each group median (range)

    Figure 2 Concentration of cytokines in vitreous fluid of patients pre-treated with IVI at different time periods prior to PPV VEGF:Vascular endothelial growth factor; IVI: Intravitreal anti-VEGF injections; bFGF: Basic fibroblast growth factor; IL: Interleukin; TNF: Tumor necrosis factor. aP<0.05 by Kruskal-Wallis H test.

    Figure 3 Correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines in patients after intravitreal injection of anti-VEGF drugs VEGF: Vascular endothelial growth factor; bFGF: Basic fibroblast growth factor; IL: Interleukin.

    Correlation of Vitreous Fluid Cytokine Concentrations and Degree of Vitreoretinal Fibrosis There was no difference in the degree of vitreoretinal fibrosis between the no IVI PDR group and IVI PDR group (χ2=1.143,P=0.911). When comparing the IVI PDR subgroups in terms of vitreoretinal fibrosis, a statistically significant difference was found(Z=8.988,P=0.011). No patient in the 3-day group exhibited vitreoretinal fibrosis of grade 3; on the contrary, in the ≥7-day group, vitreoretinal fibrosis of grade 3 occurred in 57% (4/7)of cases. Overall, the degree of vitreoretinal fibrosis increased significantly after IVI in the ≥7-day group compared to the 3-day group (P=0.015) and the 5-day group (P=0.039; Table 3).For the primary outcome, the correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines was analyzed by Spearman rank correlation test. In the IVI group,our analysis revealed that the degree of vitreoretinal fibrosis and the bFGF, PN, IL-6, and IL-8 concentrations correlated significantly (allP<0.05), with a Spearman’s value of 0.879,0.608, 0.488, and 0.529, respectively. On the contrary, the degree of vitreoretinal fibrosis did not correlate with the intravitreal concentration of VEGF (P=0.373) and TNF- α(P=0.587; Figure 3).Univariate ordinal regression analysis to determine predictors of vitreoretinal fibrosis showed that bFGF, PN, IL-6, and IL-8 concentrations had similar associations with the degree of vitreoretinal fibrosis in the IVI PDR groups (allP<0.05).In a multivariate model with bFGF, PN, IL-6, and IL-8 concentrations as predictors of vitreoretinal fibrosis, bFGF was an independent risk factor for the progression of fibrosis in PDR patients pre-treated with IVI (Table 4).

    Table 3 Comparison of the degree of fibrosis in patients pre-treated with IVI at different time periods prior to PPV

    Table 4 Ordered logistic regression analysis of vitreoretinal fibrosis

    DISCUSSION

    The development of diabetic retinopathy (DR) into advanced proliferative lesions involves a series of complicated pathological changes. From the macroscopic point of view, it is mainly the pathological changes of retinal micro-vessels,while from the microscopic, molecular, biological level, the increase or decrease of different kinds of cytokines in the eye and changes in the retinal immune microenvironment mediated by these cytokines accelerate the pathological progression of PDR. Changes in VEGF concentrations are the key event, mainly because VEGF is an important factor in retinal vascular leakage and pathological neovascularization.In this pilot study, significantly higher concentrations of VEGF were detected in the vitreous samples of PDR patients who were not pretreated with IVI compared to non-diabetic controls. In the last 10y, targeted inhibition of VEGF has been widely applied clinically as adjuvant therapy for PDR,especially as preoperative IVI prior to PPV[8-9].

    Consistent with previous reports, we found that concentrations of VEGF were significantly lower in PDR patients pretreated with IVI. As VEGF inhibitors, anti-VEGF drugs prevent VEGF from binding to VEGF receptors such as vascular endothelial growth factor receptor-2 (VEGFR-2), thereby inhibiting endothelial cell proliferation and reducing vascular leakage, thus eliminating fragile neovascularization or inhibiting its formation[21-22]. A large number of studies have confirmed that preoperative IVI combined with PPV in the treatment of PDR can not only reduce intraoperative and postoperative complications, but also improve the visual prognosis of patients[11-13].

    An important issue in combination therapy is the interval between PPV and IVI pretreatment. From the perspective of VEGF, it seems that the longer the interval time, the lower the VEGF concentration and the greater the advantage of combination therapy. Our study further compared the concentrations of VEGF in the vitreous at different time after anti-VEGF therapy, and found that VEGF concentrations decreased dramatically at 3, 5 and 7d after injection, and reached the lowest concentrations in patients who underwent PPV 5d after IVI. At present, reports on the changes in intraocular VEGF concentrations after IVI at different intervals are not consistent. Fenget al[23]proved that bevacizumab could reduce the concentration of VEGF in aqueous fluid of PDR patients and remaine low for 14d. Maet al[24]reported that VEGF concentrations in vitreous fluid of PDR patients decreased significantly after intravitreal bevacizumab injection, and this low concentration remained for 4.4±2.2 to 34.8±33.7d, with the lowest value appearing within one week after injection. Judging from the above, there is no doubt that preoperative IVI can block intraocular VEGF levels, but this inhibitory effect is time-limited, so if clinicians want to improve the success rate and postoperative outcome of PPV in PDR patients, the timing of intravitreal injection of anti-VEGF before PPV should be chosen at the peak of drug action.

    In the present study, we observed another important phenomenon: vitreoretinal fibrosis can develop or progress following IVI treatment, especially with a long interval between IVI and PPV. We compared the degree of vitreoretinal fibrosis after IVI at different times and found that grade 3 was dominant in the ≥7-day group, accounting for 57%, and the degree of vitreoretinal fibrosis was more serious than that in the 3-day group and 5-day group. El-Sabaghet al[25]showed that the longer the interval between intravitreal bevacizumab injection and PPV, the higher the degree of vitreoretinal fibrosis in eyes with PDR, while neovascularization in FVMs decreased significantly. It can be seen that vitreoretinal fibrosis will develop or progress with longer time intervals between IVI pretreatment and PPV; therefore, it is not advisable prolong the interval in clinic. Some prior studies have suggested that the above complications may be closely related to the angiofibrotic switch[19-20,26], but the mechanism of this switch has not been elucidated.

    Kuiperet al[20]discovered that the balance between connective tissue growth factor (CTGF) and VEGF determined the angiofibrotic switch, and disruption of this balance could promote the transformation from angiogenesis to fibrosis in PDR patients. Combined with our study, one possibility is that preoperative IVI not only decreased VEGF but also caused changes in the levels of other cytokines in PDR accordingly,which triggered the angio-fibrotic switch and disrupted the angio-fibrotic balance.

    Our study further analyzed the changes in concentrations of other cytokines in the vitreous fluid of PDR patients after administration of anti-VEGF drugs at different times before PPV. We observed that intraocular concentrations of bFGF and periostin were highest in the ≥7-day group and were positively correlated with the degree of vitreoretinal fibrosis. In addition,the concentrations of IL-6 and IL-8 inflammatory cytokines in the ≥7-day group were significantly higher than those in the 3-day group. The role of bFGF and PN as pro-fibrotic cytokines is well-established in various diseases and recently in retinopathy as well[27-31]. IL-6 and IL-8 are members of the IL family involved in inflammation[32-33]. The changes in the above cytokine concentrations in this study can be related to a sharp and continuous decline in VEGF levels, which causes a compensatory increase of pro-fibrosis and inflammatory cytokine concentrations. When the level of these cytokines reaches a threshold value, especially pro-fibrosis factors, the angio-fibrotic switch will be triggered, which can further upregulate the expression of pro-fibrosis cytokines. In addition,with the progression of vitreoretinal fibrosis, retinal hypoxia is aggravated, which leads to a certain degree of inflammation.Fibrosis and inflammation interact with each other, forming a vicious cycle. Therefore, the optimal timing of preoperative IVI treatment for PDR patients is when anti-VEGF drugs can minimize intraocular VEGF concentrations and do not trigger the angio-fibrotic switch. On the basis of our research, it is suggested that PPV should be performed 5d after IVI.

    In addition, it is worth mentioning that multivariate ordered logistic regression analysis showed bFGF was an independent risk factor for the progression of vitreoretinal fibrosis in active PDR patients after IVI. This suggests that bFGF may be a new target for anti-fibrosis therapy, anti-bFGF combined with anti-VEGF drugs can be considered to assist PPV in the treatment of PDR in the future.

    Our study has some limitations. First, our findings should be considered preliminary. However, our previous clinical study found that the degree of vitreoretinal fibrosis could be aggravated with prolonged interval between IVI and PPV.Such favorable outcomes require larger-scale clinical trials to be proven. Second, this study elucidated the mechanism of the“angio-fibrotic switch” only by detecting the concentration of cytokines in the vitreous fluid. Further studies with a larger sample size and immunohistochemical experiments of FVMs are needed to co-validate the data.

    In summary, in PDR patients, the vitreous concentrations of a variety of cytokines will change after pretreatment with IVI before PPV. Prolonged blocking of VEGF cytokine may trigger the “angio-fibrotic switch”. We suggest that PPV be performed on the fifth day after the administration of anti-VEGF drugs in PDR patients because VEGF concentrations in vitreous fluid reached the lowest level, and concentrations of bFGF and PN have not increased significantly. Meanwhile,the degree of vitreoretinal fibrosis can significantly increase in patients with a pretreatment interval ≥7d prior to PPV, which is mainly related to the significantly increased concentrations of bFGF, PN, IL-6, and IL-8 in the vitreous fluid. bFGF is an independent risk factor for fibrosis progression and is expected to become a new target for anti-fibrosis therapy.

    ACKNOWLEDGEMENTS

    Foundations:Supported by the Guiding Science and Technology Plan Project of Huainan City (No.2020044);Construction Project of Key Medical and Health of Anhui Province in 2021.

    Conflicts of Interest:Xu Y,None;Xie C,None;Fang Y,None;Yu Y,None;Qiu C,None.

    久久亚洲真实| 欧美成狂野欧美在线观看| 亚洲人成电影免费在线| 这个男人来自地球电影免费观看| 黄片大片在线免费观看| 黄片大片在线免费观看| 在线观看免费午夜福利视频| 国产成人一区二区三区免费视频网站| 热99re8久久精品国产| 女人被狂操c到高潮| 欧美极品一区二区三区四区| 成熟少妇高潮喷水视频| 天堂影院成人在线观看| 高潮久久久久久久久久久不卡| 成人一区二区视频在线观看| 精品久久久久久久人妻蜜臀av| 久久精品亚洲精品国产色婷小说| 小说图片视频综合网站| 精品国产超薄肉色丝袜足j| 不卡av一区二区三区| 久久久精品大字幕| 日韩有码中文字幕| 夜夜爽天天搞| 最近视频中文字幕2019在线8| 久久久久久国产a免费观看| 午夜免费观看网址| 国产一区在线观看成人免费| 亚洲全国av大片| 国产伦在线观看视频一区| 色综合婷婷激情| 日本三级黄在线观看| 成人亚洲精品av一区二区| 色av中文字幕| 久久久久国产精品人妻aⅴ院| 婷婷精品国产亚洲av在线| 九色成人免费人妻av| 男插女下体视频免费在线播放| 国产精品久久电影中文字幕| 黄色成人免费大全| 男女做爰动态图高潮gif福利片| 男女之事视频高清在线观看| 精品日产1卡2卡| 好看av亚洲va欧美ⅴa在| 亚洲全国av大片| 亚洲精品国产精品久久久不卡| 两性夫妻黄色片| 伦理电影免费视频| 亚洲国产高清在线一区二区三| 色在线成人网| 午夜影院日韩av| 91九色精品人成在线观看| 亚洲在线自拍视频| 99热这里只有是精品50| 国产区一区二久久| 午夜老司机福利片| 在线观看午夜福利视频| 十八禁人妻一区二区| 亚洲五月婷婷丁香| 1024手机看黄色片| 久久九九热精品免费| 国产精品久久久久久人妻精品电影| 哪里可以看免费的av片| 国产一区二区在线av高清观看| 久久精品综合一区二区三区| 国产蜜桃级精品一区二区三区| av国产免费在线观看| 国产又色又爽无遮挡免费看| 欧美黑人精品巨大| 1024香蕉在线观看| 一进一出好大好爽视频| 亚洲激情在线av| 老汉色av国产亚洲站长工具| 久久久久久国产a免费观看| 一个人免费在线观看的高清视频| 亚洲成人国产一区在线观看| 久久99热这里只有精品18| 午夜免费观看网址| 久久精品影院6| 19禁男女啪啪无遮挡网站| 少妇被粗大的猛进出69影院| 岛国视频午夜一区免费看| 免费在线观看完整版高清| 亚洲av美国av| 国产成年人精品一区二区| 国产真人三级小视频在线观看| 亚洲 欧美 日韩 在线 免费| 成人特级黄色片久久久久久久| 国产av在哪里看| 97人妻精品一区二区三区麻豆| 国产av不卡久久| 黄频高清免费视频| 色精品久久人妻99蜜桃| 国产欧美日韩一区二区精品| 国产区一区二久久| 99热这里只有是精品50| 国内精品一区二区在线观看| 777久久人妻少妇嫩草av网站| 亚洲熟女毛片儿| 国产精品久久久久久亚洲av鲁大| 两个人免费观看高清视频| 免费高清视频大片| 久久人妻福利社区极品人妻图片| 欧美日韩乱码在线| 亚洲成av人片免费观看| 精品欧美一区二区三区在线| 免费在线观看日本一区| 国产乱人伦免费视频| 欧美+亚洲+日韩+国产| 国产在线观看jvid| 老汉色av国产亚洲站长工具| 十八禁人妻一区二区| 最新在线观看一区二区三区| 制服人妻中文乱码| 久久久久免费精品人妻一区二区| 熟女电影av网| 日韩欧美精品v在线| 午夜免费观看网址| 精品国产乱码久久久久久男人| 免费看十八禁软件| 精品无人区乱码1区二区| 国产精品 欧美亚洲| 看黄色毛片网站| 夜夜看夜夜爽夜夜摸| 18禁黄网站禁片免费观看直播| 岛国视频午夜一区免费看| 哪里可以看免费的av片| 老鸭窝网址在线观看| 国产区一区二久久| 美女扒开内裤让男人捅视频| 亚洲国产精品久久男人天堂| 成年版毛片免费区| 亚洲18禁久久av| 国产成人aa在线观看| 国产熟女xx| 午夜福利欧美成人| 99精品久久久久人妻精品| 黑人操中国人逼视频| 亚洲成人中文字幕在线播放| 成年人黄色毛片网站| 精品高清国产在线一区| 丰满的人妻完整版| 无人区码免费观看不卡| 最近最新中文字幕大全电影3| 一级毛片精品| 在线a可以看的网站| 天天躁狠狠躁夜夜躁狠狠躁| 欧美日韩中文字幕国产精品一区二区三区| 亚洲国产精品成人综合色| av福利片在线| 成人18禁高潮啪啪吃奶动态图| 欧美日韩瑟瑟在线播放| 亚洲精品一区av在线观看| 国产午夜精品久久久久久| 午夜免费激情av| 亚洲男人的天堂狠狠| 成人永久免费在线观看视频| 全区人妻精品视频| av欧美777| 国产精品av久久久久免费| av福利片在线| 久久人妻av系列| 亚洲色图av天堂| 亚洲乱码一区二区免费版| 国产黄a三级三级三级人| 日韩av在线大香蕉| 国产精品美女特级片免费视频播放器 | 久久久久久免费高清国产稀缺| 在线观看一区二区三区| 我要搜黄色片| 两人在一起打扑克的视频| 国产av麻豆久久久久久久| 午夜激情av网站| 日韩欧美国产一区二区入口| 男女做爰动态图高潮gif福利片| 亚洲,欧美精品.| 成人午夜高清在线视频| 亚洲五月婷婷丁香| av片东京热男人的天堂| 国产又黄又爽又无遮挡在线| 国产日本99.免费观看| 久久伊人香网站| 成熟少妇高潮喷水视频| 中文字幕av在线有码专区| 日韩中文字幕欧美一区二区| 免费在线观看完整版高清| 真人一进一出gif抽搐免费| 男人舔奶头视频| 国产精品爽爽va在线观看网站| 老司机福利观看| 欧美三级亚洲精品| 舔av片在线| 法律面前人人平等表现在哪些方面| 三级国产精品欧美在线观看 | 久久这里只有精品19| 午夜激情av网站| 久久久久久国产a免费观看| 校园春色视频在线观看| 国产三级中文精品| 国产精华一区二区三区| 在线十欧美十亚洲十日本专区| 亚洲,欧美精品.| 成年免费大片在线观看| 亚洲精品中文字幕在线视频| 一夜夜www| 亚洲在线自拍视频| 男女做爰动态图高潮gif福利片| 女警被强在线播放| 老司机在亚洲福利影院| 久久人妻福利社区极品人妻图片| 国产成人av激情在线播放| 国产成人系列免费观看| 一进一出抽搐动态| 欧美精品亚洲一区二区| 国产三级黄色录像| 欧美日韩亚洲国产一区二区在线观看| 亚洲精品一区av在线观看| 国产成人影院久久av| 国产亚洲精品一区二区www| 亚洲激情在线av| 亚洲免费av在线视频| 亚洲人成网站在线播放欧美日韩| 日本a在线网址| 人妻丰满熟妇av一区二区三区| 五月伊人婷婷丁香| 99热6这里只有精品| 国产精品1区2区在线观看.| 巨乳人妻的诱惑在线观看| 制服丝袜大香蕉在线| 久久九九热精品免费| 黄色a级毛片大全视频| 一边摸一边做爽爽视频免费| 麻豆一二三区av精品| 精品不卡国产一区二区三区| 色综合亚洲欧美另类图片| 中亚洲国语对白在线视频| 性欧美人与动物交配| 国产av麻豆久久久久久久| 午夜影院日韩av| 在线观看美女被高潮喷水网站 | 老熟妇仑乱视频hdxx| 日本 欧美在线| 午夜日韩欧美国产| 亚洲熟妇中文字幕五十中出| 国产片内射在线| 国产男靠女视频免费网站| 十八禁人妻一区二区| 欧美 亚洲 国产 日韩一| 深夜精品福利| 国内久久婷婷六月综合欲色啪| 女人高潮潮喷娇喘18禁视频| 久久九九热精品免费| 手机成人av网站| 久久精品综合一区二区三区| 国产探花在线观看一区二区| 国产精品免费一区二区三区在线| 午夜成年电影在线免费观看| 国产成人系列免费观看| 亚洲成a人片在线一区二区| 欧美日韩黄片免| 啪啪无遮挡十八禁网站| 国产亚洲精品av在线| 岛国视频午夜一区免费看| 久久中文看片网| 1024手机看黄色片| 精品国产超薄肉色丝袜足j| 俄罗斯特黄特色一大片| 日韩欧美在线乱码| 亚洲精品粉嫩美女一区| 一级毛片女人18水好多| 美女高潮喷水抽搐中文字幕| 亚洲第一电影网av| 日韩欧美精品v在线| 可以在线观看的亚洲视频| 亚洲人成网站在线播放欧美日韩| 最近最新免费中文字幕在线| 岛国在线观看网站| 欧美日韩乱码在线| 亚洲一区二区三区不卡视频| 久久久久久大精品| 免费在线观看日本一区| 久久天堂一区二区三区四区| 亚洲第一电影网av| 美女免费视频网站| e午夜精品久久久久久久| 欧美一区二区精品小视频在线| 午夜福利在线观看吧| 韩国av一区二区三区四区| 欧美黑人欧美精品刺激| 亚洲精品国产一区二区精华液| 男女午夜视频在线观看| 99热6这里只有精品| 变态另类成人亚洲欧美熟女| 香蕉av资源在线| a在线观看视频网站| 女人被狂操c到高潮| 岛国在线观看网站| 一进一出好大好爽视频| 一级作爱视频免费观看| 亚洲国产日韩欧美精品在线观看 | 狂野欧美激情性xxxx| 久久精品国产综合久久久| 欧美av亚洲av综合av国产av| 99久久无色码亚洲精品果冻| 亚洲欧洲精品一区二区精品久久久| 黄色成人免费大全| www.999成人在线观看| 精品欧美国产一区二区三| 国产av麻豆久久久久久久| 在线视频色国产色| 日本 欧美在线| 黄色a级毛片大全视频| 色在线成人网| 久久亚洲真实| 久久热在线av| 国产精品影院久久| 国产成人精品久久二区二区91| 国产aⅴ精品一区二区三区波| 人妻夜夜爽99麻豆av| a级毛片a级免费在线| 少妇的丰满在线观看| 国产黄片美女视频| 亚洲精品美女久久av网站| 日本撒尿小便嘘嘘汇集6| 国产精品一区二区精品视频观看| 99精品欧美一区二区三区四区| 精品无人区乱码1区二区| 婷婷亚洲欧美| 免费电影在线观看免费观看| 三级毛片av免费| 女同久久另类99精品国产91| 国产私拍福利视频在线观看| 亚洲欧美日韩高清专用| 人人妻人人看人人澡| 午夜影院日韩av| 久久天躁狠狠躁夜夜2o2o| 亚洲av中文字字幕乱码综合| 天天躁狠狠躁夜夜躁狠狠躁| 男插女下体视频免费在线播放| 日日爽夜夜爽网站| 亚洲成人精品中文字幕电影| 日韩高清综合在线| 亚洲国产日韩欧美精品在线观看 | 久久久久免费精品人妻一区二区| 国产精品久久久久久精品电影| 在线观看免费午夜福利视频| 搞女人的毛片| 国产蜜桃级精品一区二区三区| 日本一区二区免费在线视频| 亚洲最大成人中文| 免费高清视频大片| 婷婷丁香在线五月| 精品一区二区三区视频在线观看免费| 听说在线观看完整版免费高清| 级片在线观看| 在线视频色国产色| 91国产中文字幕| 亚洲午夜理论影院| 国产精品久久久av美女十八| 久久精品成人免费网站| 人人妻人人看人人澡| 中文字幕人成人乱码亚洲影| 高清毛片免费观看视频网站| 日日爽夜夜爽网站| 亚洲国产看品久久| 久久天躁狠狠躁夜夜2o2o| 黄色毛片三级朝国网站| 国产在线观看jvid| 男人的好看免费观看在线视频 | 久久精品影院6| 欧美色欧美亚洲另类二区| 天天一区二区日本电影三级| 中文字幕人妻丝袜一区二区| 无人区码免费观看不卡| 国产精品亚洲美女久久久| 三级国产精品欧美在线观看 | 国产午夜精品久久久久久| 少妇的丰满在线观看| 婷婷精品国产亚洲av| 欧美黑人欧美精品刺激| 免费在线观看成人毛片| 一区二区三区激情视频| 国产精品爽爽va在线观看网站| 日韩欧美国产在线观看| 伊人久久大香线蕉亚洲五| 亚洲精华国产精华精| 国产精品电影一区二区三区| 三级国产精品欧美在线观看 | 免费观看人在逋| 亚洲天堂国产精品一区在线| 色噜噜av男人的天堂激情| 久久草成人影院| 国产精品影院久久| 国产精华一区二区三区| 国产精品电影一区二区三区| 日韩精品青青久久久久久| 岛国在线免费视频观看| 国产1区2区3区精品| 日韩欧美一区二区三区在线观看| 女警被强在线播放| 黑人巨大精品欧美一区二区mp4| 91成年电影在线观看| 亚洲av成人精品一区久久| 人人妻人人澡欧美一区二区| 亚洲色图 男人天堂 中文字幕| 在线十欧美十亚洲十日本专区| videosex国产| 夜夜躁狠狠躁天天躁| 久久亚洲精品不卡| 久久久久性生活片| 亚洲一区二区三区色噜噜| 国产成人精品久久二区二区91| 一区二区三区国产精品乱码| 日韩欧美三级三区| 日韩欧美在线二视频| 女人高潮潮喷娇喘18禁视频| 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲av成人一区二区三| 国产精品一区二区三区四区久久| 成人18禁在线播放| 久久久久久九九精品二区国产 | 精品不卡国产一区二区三区| 又大又爽又粗| 两个人的视频大全免费| x7x7x7水蜜桃| av在线播放免费不卡| 色尼玛亚洲综合影院| 免费电影在线观看免费观看| 国产激情偷乱视频一区二区| 久久精品综合一区二区三区| 欧美 亚洲 国产 日韩一| 国产精品久久久久久人妻精品电影| 精品少妇一区二区三区视频日本电影| 亚洲一卡2卡3卡4卡5卡精品中文| 国产三级在线视频| 国产激情久久老熟女| 国产精品,欧美在线| 久久热在线av| a级毛片a级免费在线| 两性午夜刺激爽爽歪歪视频在线观看 | 国产av又大| 亚洲一区中文字幕在线| 久久久久久国产a免费观看| 久久国产精品人妻蜜桃| 日本 av在线| 欧美丝袜亚洲另类 | 亚洲天堂国产精品一区在线| 国产不卡一卡二| 亚洲欧美激情综合另类| 日韩欧美免费精品| 高清在线国产一区| 国产在线观看jvid| 黄色片一级片一级黄色片| 国产精品亚洲一级av第二区| 精品免费久久久久久久清纯| 在线国产一区二区在线| 国产精品一区二区三区四区久久| 欧美日韩亚洲国产一区二区在线观看| 欧美又色又爽又黄视频| 欧美成狂野欧美在线观看| 国产精品一区二区三区四区免费观看 | 亚洲欧洲精品一区二区精品久久久| 亚洲国产欧洲综合997久久,| 国产1区2区3区精品| 制服丝袜大香蕉在线| 久热爱精品视频在线9| 一本一本综合久久| 午夜免费成人在线视频| 亚洲激情在线av| 级片在线观看| 久久久国产精品麻豆| 精品高清国产在线一区| 男女下面进入的视频免费午夜| 别揉我奶头~嗯~啊~动态视频| 白带黄色成豆腐渣| а√天堂www在线а√下载| 久久久久免费精品人妻一区二区| 久久久国产精品麻豆| 国产99久久九九免费精品| 久久精品aⅴ一区二区三区四区| 成年免费大片在线观看| 久久欧美精品欧美久久欧美| 亚洲欧美日韩高清专用| 不卡一级毛片| cao死你这个sao货| 九色国产91popny在线| 两个人免费观看高清视频| 日韩有码中文字幕| av免费在线观看网站| 国产高清有码在线观看视频 | 悠悠久久av| 国产成人影院久久av| 日韩精品中文字幕看吧| 99国产精品一区二区蜜桃av| 精品福利观看| 欧美黑人巨大hd| 亚洲午夜精品一区,二区,三区| 男女之事视频高清在线观看| 久久久久免费精品人妻一区二区| 最近视频中文字幕2019在线8| 中文字幕高清在线视频| 琪琪午夜伦伦电影理论片6080| 可以在线观看毛片的网站| 深夜精品福利| 欧洲精品卡2卡3卡4卡5卡区| 成年版毛片免费区| 在线观看美女被高潮喷水网站 | 99国产精品99久久久久| 香蕉av资源在线| 亚洲免费av在线视频| 床上黄色一级片| 欧美日韩亚洲国产一区二区在线观看| 村上凉子中文字幕在线| 桃色一区二区三区在线观看| 久久久久久九九精品二区国产 | 变态另类成人亚洲欧美熟女| 亚洲av第一区精品v没综合| 丁香六月欧美| 亚洲av日韩精品久久久久久密| 亚洲天堂国产精品一区在线| 国产蜜桃级精品一区二区三区| 两个人看的免费小视频| 成在线人永久免费视频| 熟女电影av网| 午夜激情福利司机影院| 一级a爱片免费观看的视频| 成人国语在线视频| 国产三级中文精品| 操出白浆在线播放| av中文乱码字幕在线| 成人18禁在线播放| 一个人免费在线观看的高清视频| 在线观看66精品国产| x7x7x7水蜜桃| 国产私拍福利视频在线观看| 好看av亚洲va欧美ⅴa在| 桃红色精品国产亚洲av| 久久久国产欧美日韩av| 国产成人av激情在线播放| 免费观看人在逋| 妹子高潮喷水视频| 免费看日本二区| www.999成人在线观看| 亚洲欧美日韩东京热| 精品欧美国产一区二区三| 少妇人妻一区二区三区视频| 亚洲天堂国产精品一区在线| 国产精品爽爽va在线观看网站| 在线观看66精品国产| 在线看三级毛片| 一进一出好大好爽视频| 国产伦在线观看视频一区| 毛片女人毛片| 中文字幕人成人乱码亚洲影| 可以在线观看毛片的网站| 久久亚洲真实| 亚洲专区中文字幕在线| 国产精品永久免费网站| 叶爱在线成人免费视频播放| 亚洲国产高清在线一区二区三| 国产精品亚洲av一区麻豆| 日韩欧美一区二区三区在线观看| 看黄色毛片网站| 国产成人影院久久av| 无遮挡黄片免费观看| 中文字幕久久专区| 久久精品国产亚洲av高清一级| 黄色 视频免费看| 国产激情久久老熟女| 国产精品爽爽va在线观看网站| 国产亚洲精品久久久久久毛片| 两人在一起打扑克的视频| 深夜精品福利| 国内精品一区二区在线观看| 久久性视频一级片| 丁香欧美五月| 亚洲 欧美一区二区三区| 国产精品 国内视频| 国产三级中文精品| 九色国产91popny在线| 国产伦人伦偷精品视频| 黄色 视频免费看| 亚洲男人的天堂狠狠| 淫秽高清视频在线观看| 熟女电影av网| 老司机福利观看| 90打野战视频偷拍视频| 亚洲电影在线观看av| 成熟少妇高潮喷水视频| 90打野战视频偷拍视频| 精品国产超薄肉色丝袜足j| 精品日产1卡2卡| 国产午夜精品久久久久久| 99国产精品一区二区三区| 色精品久久人妻99蜜桃| 亚洲中文字幕一区二区三区有码在线看 | 国产精品免费一区二区三区在线| 一级毛片女人18水好多| 99国产综合亚洲精品| 婷婷亚洲欧美| 欧美成狂野欧美在线观看| 又粗又爽又猛毛片免费看| 久久久久国产一级毛片高清牌| 中文字幕人成人乱码亚洲影| 亚洲天堂国产精品一区在线| 哪里可以看免费的av片| 欧美乱码精品一区二区三区| 日韩av在线大香蕉| 两个人的视频大全免费| 国产97色在线日韩免费| 一区福利在线观看| 日韩大尺度精品在线看网址| 中文字幕熟女人妻在线| 色老头精品视频在线观看| 两性夫妻黄色片| 人人妻人人澡欧美一区二区|